An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Liver cancer might be on the rise as a silent epidemic. However, awareness coupled with cutting-edge treatments turn out to be a boon for the same. While Cutting-edge technology can offer ...

In December, Detroit-based Barbara Ann Karmanos Cancer Center became the first facility in the world to offer at-home liver cancer treatment with the TheraBionic P1, a device recently approved by ...

What Are Stage III and Stage IV Ovarian Cancer? Stage III ovarian cancer is when the cancer is not just found in one or both ovaries but has spread outside the pelvis to the abdomen, nearby lymph ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherapy through ...

Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Namodenoson is currently being evaluated in a pivotal Phase III trial for advanced liver cancer, a Phase IIb trial for the treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH), and ...